Fixes Book Closure for Dividend & A G M
Jagsonpal Pharmaceuticals Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 27, 2013 to September 30, 2013 (both days inclusive) for the purpose of Payment of Dividend & Annual General Meeting (AGM) of the Company. Financial Results & Limited Review for June 30, 2013
Jagsonpal Pharmaceuticals Ltd has informed BSE about the Financial Results & a copy of the Limited Review Report for the period ended June 30, 2013. Board recommends Dividend
Jagsonpal Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2013, inter alia, has recommended dividend of Rs. 0.50/- per Equity Share of Rs. 5/- each. Financial Results & Auditors Report for March 31, 2013 (Audited)
Jagsonpal Pharmaceuticals Ltd has informed BSE about the Financial Results & a copy of the Auditors Report for the period ended March 31, 2013. Board to consider Dividend
Jagsonpal Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 30, 2013 to :1. Consider and Approve the Audited financial results for the quarter/year ended March 31, 2013.2. Recommend dividend, if any, for the year ended March 31, 2013. Change in directorship
Jagsonpal Pharmaceuticals Ltd has informed BSE regarding "Change in directorship" Change in Company Secretary & Compliance Officer
Jagsonpal Pharmaceuticals Ltd has informed BSE that the Company Secretary of the Company Mr. S. K. Mata, F.C.S. has resigned from his post and Mr. Raj Kumar Kapoor has been appointed as Compliance officer cum Company Secretary w.e.f. March 20, 2013. Financial Results & Limited Review for Dec 31, 2012
Jagsonpal Pharmaceuticals Ltd has informed BSE about the Financial Results & a copy of the Limited Review Report for the period ended December 31, 2012. Financial Results & Limited Review for Sep 30, 2012
Jagsonpal Pharmaceuticals Ltd has informed BSE about the Financial Results & a copy of the Limited Review Report for the period ended September 30, 2012.